VORINOSTAT

Vorinostat is an HDAC inhibitor used for cutaneous Tcell lymphoma, altering gene expression and inducing apoptosis. Side effects include fatigue, diarrhea, thrombocytopenia, and hyperglycemia. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 8c156f057475 Category: Tags: ,

Product Description


Mechanism of Action

VORINOSTAT exhibits a highdimensional biochemical interaction matrix spanning signallingaxis disruption, catalyticdomain modulation, mitochondrialnetwork recalibration, ionflux redistribution, cytoskeletalarchitecture remodelling, membranepotential rebalancing and transcriptionfactor pathway restructuring. Its molecular topology supports interaction with catalytic residues, allosteric regulators, transmembrane helices, nucleotidebinding pockets, redoxbuffer modules and polymeric scaffolding complexes, enabling wideband influence across metabolic, structural, genomic and electrophysiological domains.

Mechanistically, VORINOSTAT may reshape phosphorylation maps across ERK/MAPK/JNK/p38 axes, alter PI3KAKT survivalbias, modulate Gprotein coupling geometry, redistribute Ca²⁺ microdomain waveforms, adjust IP/DAG signalling topology and recalibrate cAMPPKA amplitude. Mitochondrial impacts include ETCcomplex rebalancing, ATP/ADP cycle modulation, ROSthreshold displacement, mitochondrial membranepotential polarity shifts and crossorganelle stress signalling.

HighPrecision

  • Kinomescale interference & catalyticcascade modelling
  • Highresolution docking & conformationalflow prediction
  • UPR/ERstress & autophagy/mitophagy integration networks
  • Full multiomics reconstruction (RNAseq, proteomics, phosphoproteomics, metabolomics)
  • Cytoskeletal forcemapping & polymer turnover dynamics
  • Cellfate modelling: apoptosis, necroptosis, ferroptosis, parthanatos
  • AIdriven SAR/QSAR predictive simulation

Toxicodynamics & Cellular Hazard Spectrum

  • Excessive ROS accumulation & antioxidantbuffer collapse
  • Mitochondrial fragmentation or ETC suppression
  • Hyperdisruption of Na⁺/K⁺/Ca²⁺ ionicgradients
  • Cytoskeletal degradation & membrane-integrity failure
  • Inflammatory masterswitch activation (NF-κB/STAT/IRF)
  • Multiaxis programmed-cell-death induction
  • Epigenetic drift across methylation & acetylation layers

For expert laboratory research only not intended for biological use.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C14H20N2O3

Molecular Weight

264.32 g/mol

CAS Number

149647-78-9

Storage Condition

Store at 20-25 °C (68-77 °F), excursions permitted between 15-30 °C (59-86 °F).

Solubility

Slightly soluble in ethanol, isopropanol and acetone; freely soluble in dimethylsulfide; insoluble in methylene chloride

Purity

Purity information is available upon request (COA).

Synonym

Vorinostat; 149647-78-9; SAHA; suberoylanilide hydroxamic acid; N-hydroxy-N'-phenyloctanediamide

IUPAC/Chemical Name

N'-hydroxy-N-phenyloctanediamide

InChl Key

WAEXFXRVDQXREF-UHFFFAOYSA-N

InChl Code

InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18)

References

https://pubchem.ncbi.nlm.nih.gov/compound/5311;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download